Morphine-induced hallucinations - Resolution with switching to oxycodone: A case report and review of the literature

Cases Journal

Volumn 2, Issue 12, 2009, Pages

  Chowdhury, Mursheda Mahbub ^a   Board, Richard ^b  

^a St Michael's Hospice ^*  (United Kingdom)

^b St Michael's Hospice   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIZINE; DIAMORPHINE; HALOPERIDOL; LEVOMEPROMAZINE; OXYCODONE;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DELIRIUM; DIFFERENTIAL DIAGNOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HALLUCINATION; HOSPICE CARE; HOSPITAL DISCHARGE; HUMAN; MALE; MEDICAL LITERATURE; NAUSEA; NAUSEA AND VOMITING; PAIN; PROPHYLAXIS; RECURRENT DISEASE; SLEEP WAKING CYCLE;

EID: 77953474654     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.1186/1757-1626-2-9391     Document Type: Article

References (12)

1. Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, Mercadante S, Pasternak G, Ventafridda V: Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001, 19(9):2542-2554.
2. Bruera E, Franco JJ, Maltoni M, Watanabe S, Suarez-Almazor M: Changing pattern of agitated impaired mental state in patients with advanced cancer: association with cognitive monitoring, hydration and opioid rotation. J Pain Symptom Manage 1995, 10(4):287-291.
3. Hanks G, Cherny N, Fallon M: From opioid analgesic therapy. In The Oxford Textbook of Palliative Medicine 3rd edition. Edited by: Doyle D, Hanks G, Cherny N, Calman K. New York: Oxford University Press; 2005:331-335.
4. Galer BS, Coyle N, Pasternak GW, Portenoy RK: Individual variability in the response to different opioids: report of five cases. Pain 1992, 49:87-91.
5. de Stoutz N, Bruera E, Suarez-Almazor M: Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 1995, 10(5):378-384.
6. Ross JR, Riley J, Quigley C, Welsh K: Clinical pharmacology and pharmacotherapy of opioid switching in cancer patients. Oncologist 2006, 11(7):765-773.
7. Riley J, Ross JR, Rutter D, Shah S, Gwilliam B, Wells AU, Welsh K: A retrospective study of the association between haematological and biochemical parameters and morphine intolerance in patients with cancer pain. Palliat Med 2004, 18:19-24.
8. Maddocks I, Somogyi A, Abbott F, Haybail P, Parker P: Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone. J Pain Symptom Manage 1996, 12(3):182-189.
9. Cairns R: The use of oxycodone in cancer-related pain: a literature review. Int J Palliat Nurs 2001, 7(11):522-527.
10. Riley R, Ross JR, Rutter D, Wells AU, Goller K, du Bois R, Welsh K: No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. Support Care Cancer 2006, 14:56-64.
11. McNamara P: Opioid switching from morphine to transdermal fentanyl for toxicity reduction in palliative care. Palliat Med 2002, 16:425-434.
12. Indelicato RA, Portenoy RK: Opioid rotation in the management of refractory cancer pain. J Clin Oncol 2003, 21(Suppl 9):87-91.